Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.7127
+0.0047 (0.66%)
Dec 29, 2025, 1:42 PM EST - Market open
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $14.84 million as of December 29, 2025. Its market cap has decreased by -30.42% in one year.
Market Cap
14.84M
Enterprise Value
9.17M
1-Year Change
-30.42%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $14.84M, a decrease of -55.56%. That is a compound annual growth rate of -47.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 14.74M | -24.51% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |